Canaccord Genuity raises Beam Therapeutics target to $79 from $78
Valid market news retained in the public archive without immediate LiveCast distribution.
Related stories
Rafael Holdings reports Q4 net loss
Rafael Holdings reported Q4 operating income of USD -9.731 million.
M impact | EQUITY | Oct 29, 2026, 12:20 PM UTC
Medical Properties Trust Reports Q3 Revenue of $250.1 Million
Medical Properties Trust reported Q3 revenue of $250.1 million, versus a FactSet estimate of $256.9 million.
M impact | EQUITY | Oct 29, 2026, 12:20 PM UTC
Patrick Industries Reports Q3 Revenue of $975.3M
Patrick Industries reported Q3 revenue of $975.3 million, versus a FactSet estimate of $938.5 million.
M impact | EQUITY | Oct 29, 2026, 12:10 PM UTC
Third Space Partners Acquires Quest Events
Third Space Partners acquired Quest Events, which provides live event drape and modular scenic solutions.
M impact | EQUITY | Oct 29, 2026, 12:08 PM UTC
CNX Resources Shares Rise After Q3 Profit and Revenue Beat
CNX Resources shares rose 3.37% in premarket trading after third-quarter core profit and revenue exceeded expectations.
M impact | EQUITY | Oct 29, 2026, 12:07 PM UTC
Ibovespa futures fall in early trading
M impact | EQUITY | Oct 29, 2026, 12:07 PM UTC